[S02DA03, antipyrine, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Antipyrine.]
[J01GA01, streptomycin, Framycetin may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[M03AB01, succinylcholine, The therapeutic efficacy of Succinylcholine can be increased when used in combination with Framycetin.]
[A02BX02, sucralfate, Framycetin may decrease the excretion rate of Sucralfate which could result in a higher serum level.]
[J01CG01, sulbactam, Framycetin may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01CA16, sulbenicillin, The serum concentration of Framycetin can be decreased when it is combined with Sulbenicillin.]
[J01EC02, sulfadiazine, Framycetin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Framycetin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[M01AB02, sulindac, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Sulindac.]
[M01AX04, apazone, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Azapropazone.]
[J01CA15, talampicillin, The serum concentration of Framycetin can be decreased when it is combined with Talampicillin.]
[N05CD07, temazepam, Framycetin may decrease the excretion rate of Temazepam which could result in a higher serum level.]
[R03CC03, terbutaline, Framycetin may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Framycetin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Framycetin may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Tetracaine.]
[S03AA02, tetracycline, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Tetracycline.]
[J01DI02, ceftaroline fosamil, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Ceftaroline fosamil.]
[P02CA02, thiabendazole, Framycetin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, Framycetin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.]
[G04BE06, moxisylyte, Framycetin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Framycetin may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[J01CA13, ticarcillin, The serum concentration of Framycetin can be decreased when it is combined with Ticarcillin.]
[B01AC05, ticlopidine, Framycetin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.]
[S01ED01, timolol, Framycetin may decrease the excretion rate of Timolol which could result in a higher serum level.]
[P01AB02, tinidazole, Framycetin may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Framycetin may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Framycetin may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[V04CA01, tolbutamide, Framycetin may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Tolmetin.]
[N02AX02, tramadol, Framycetin may decrease the excretion rate of Tramadol which could result in a higher serum level.]
[C03DB02, triamterene, The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Framycetin.]
[N05CD05, triazolam, Framycetin may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[A16AX12, trientine, Framycetin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, Framycetin may decrease the excretion rate of Trifluridine which could result in a higher serum level.]
[A03AA05, trimebutine, Framycetin may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Framycetin is combined with Trimethaphan.]
[J01EA01, trimethoprim, Framycetin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be increased when used in combination with Framycetin.]
[R03DX07, roflumilast, Framycetin may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Framycetin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Framycetin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[S01AA28, vancomycin, Framycetin may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Framycetin may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Framycetin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, Framycetin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N06AX09, viloxazine, Framycetin may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[B03BA01, vitamin B12, Framycetin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.]
[B01AA03, warfarin, Framycetin may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[M05BA03, pamidronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Framycetin is combined with Pamidronic acid.]
[M05BA05, tiludronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Framycetin is combined with Tiludronic acid.]
[B06AC02, icatibant, Framycetin may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[A02BC04, rabeprazole, Framycetin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Framycetin is combined with Ibandronate.]
[V03AC02, deferiprone, Framycetin may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, Framycetin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Framycetin may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Framycetin may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[M03AC04, atracurium, The therapeutic efficacy of Atracurium can be increased when used in combination with Framycetin.]
[M01CB03, auranofin, Framycetin may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[B03XA04, peginesatide, Framycetin may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Framycetin may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Framycetin may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Framycetin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.]
[J01CA09, azlocillin, The serum concentration of Framycetin can be decreased when it is combined with Azlocillin.]
[J01DF01, aztreonam, Framycetin may decrease the excretion rate of Aztreonam which could result in a higher serum level.]
[R02AB04, bacitracin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Bacitracin.]
[M03BX01, baclofen, Framycetin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A08AA11, lorcaserin, Framycetin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Framycetin may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[L02BB04, enzalutamide, Framycetin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[A02AA05, magnesium silicate, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium silicate.]
[D02BA02, octinoxate, Framycetin may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[N04BD02, rasagiline, Framycetin may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[V09IX04, fluorodeoxyglucose F18, Framycetin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[V08CA11, gadofosveset, Framycetin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[A16AX08, teduglutide, Framycetin may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Framycetin may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Framycetin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[L04AX06, pomalidomide, Framycetin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Benorilate.]
[A10BK02, canagliflozin, Framycetin may decrease the excretion rate of Canagliflozin which could result in a higher serum level.]
[A12CC09, magnesium orotate, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium orotate.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Benzocaine.]
[L03AA12, ancestim, Framycetin may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Celecoxib.]
[A12CC05, magnesium aspartate, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium aspartate.]
[N04AC01, benztropine, Framycetin may decrease the excretion rate of Benzatropine which could result in a higher serum level.]
[R02AX03, benzydamine, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Benzydamine.]
[L01EE01, trametinib, Framycetin may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Framycetin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Framycetin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[A10BJ03, lixisenatide, Framycetin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Framycetin may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Framycetin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Framycetin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.]
[J05AP08, sofosbuvir, Framycetin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[C01CA27, droxidopa, Framycetin may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, Framycetin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Framycetin may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Framycetin may decrease the excretion rate of Formestane which could result in a higher serum level.]
[V03AB34, fomepizole, Framycetin may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Framycetin is combined with Acenocoumarol.]
[V08AA01, diatrizoic acid, Framycetin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[V08AA04, iothalamic acid, Framycetin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Dihydrostreptomycin.]
[V04CX03, methacholine, The therapeutic efficacy of Methacholine can be decreased when used in combination with Framycetin.]
[S03AA06, gentamicin, Framycetin may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Framycetin is combined with Dicoumarol.]
[B01AF03, edoxaban, Framycetin may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N02BE01, acetaminophen, Framycetin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.]
[L01DC01, bleomycin, Framycetin may decrease the excretion rate of Bleomycin which could result in a higher serum level.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Framycetin is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Adefovir dipivoxil.]
[M02AA25, aceclofenac, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Acemetacin.]
[V03AB37, idarucizumab, Framycetin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, Framycetin may increase the nephrotoxic activities of Tenofovir alafenamide.]
[L01XG03, ixazomib, Framycetin may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[M04AB05, lesinurad, Framycetin may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Alminoprofen.]
[N03AX23, brivaracetam, Framycetin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[N05BA08, bromazepam, Framycetin may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium Aluminum Silicate.]
[C03CA02, bumetanide, The serum concentration of Framycetin can be increased when it is combined with Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Bupivacaine.]
[N05BE01, buspirone, Framycetin may decrease the excretion rate of Buspirone which could result in a higher serum level.]
[L01XX27, arsenic trioxide, Framycetin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[M02AA03, clofezone, Framycetin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[J01CE04, azidocillin, The serum concentration of Framycetin can be decreased when it is combined with Azidocillin.]
[J01CA06, bacampicillin, The serum concentration of Framycetin can be decreased when it is combined with Bacampicillin.]
[A07EC04, balsalazide, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Balsalazide.]
[A06AH05, naldemedine, Framycetin may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Framycetin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Framycetin may decrease the excretion rate of Pregabalin which could result in a higher serum level.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Oxybuprocaine.]
[P01CA02, benznidazole, Framycetin may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, Framycetin may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[N07XX13, valbenazine, Framycetin may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[N07AB02, bethanechol, The therapeutic efficacy of Bethanechol can be decreased when used in combination with Framycetin.]
[J01MA23, delafloxacin, Framycetin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[S01EB09, acetylcholine, The therapeutic efficacy of Acetylcholine can be decreased when used in combination with Framycetin.]
[L01BC06, capecitabine, Framycetin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C07AB07, bisoprolol, Framycetin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.]
[J01DC10, cefprozil, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefprozil.]
[R03BA02, budesonide, Framycetin may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Bumadizone.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Capsaicin.]
[R06AX18, acrivastine, Framycetin may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[S01EB02, carbachol, The therapeutic efficacy of Carbamoylcholine can be decreased when used in combination with Framycetin.]
[L02BB05, apalutamide, Framycetin may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, Framycetin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01CA03, carbenicillin, The serum concentration of Framycetin can be decreased when it is combined with Carbenicillin.]
[L04AA37, baricitinib, Framycetin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, The risk or severity of ototoxicity and nephrotoxicity can be increased when Cefepime is combined with Framycetin.]
[J01DD10, cefetamet, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefetamet.]
[J01DD09, cefodizime, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefodizime.]
[J01DC11, ceforanide, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Ceforanide.]
[J01DD13, cefpodoxime, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefpodoxime.]
[J01DD14, ceftibuten, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Ceftibuten.]
[J01GB14, plazomicin, Framycetin may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[A16AX14, migalastat, Framycetin may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, Framycetin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01GX12, cetirizine, Framycetin may decrease the excretion rate of Cetirizine which could result in a higher serum level.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Framycetin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Lornoxicam.]
[N07XX15, inotersen, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Inotersen.]
[L01AD01, carmustine, Framycetin may decrease the excretion rate of Carmustine which could result in a higher serum level.]
[A06AX05, prucalopride, Framycetin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC23, cilostazol, Framycetin may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[N06BA14, solriamfetol, Framycetin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, Framycetin may decrease the excretion rate of Clobazam which could result in a higher serum level.]
[J01AA11, clomocycline, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Clomocycline.]
[J01DC04, cefaclor, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefaclor.]
[J01DB05, cefadroxil, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefadroxil.]
[J01DC03, cefamandole, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefamandole.]
[J01DB07, cefatrizine, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefatrizine.]
[J01DB04, cefazolin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefazolin.]
[J01CF03, methicillin, The serum concentration of Framycetin can be decreased when it is combined with Meticillin.]
[J01DC09, cefmetazole, The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Framycetin.]
[J01DC06, cefonicid, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefonicid.]
[J01DD12, cefoperazone, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefoperazone.]
[J01DD01, cefotaxime, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefotaxime.]
[J01DC05, cefotetan, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefotetan.]
[J01DC07, cefotiam, The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Framycetin.]
[J01DC01, cefoxitin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefoxitin.]
[J01DD03, cefsulodin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefsulodin.]
[J01DD02, ceftazidime, The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Framycetin.]
[J01DD07, ceftizoxime, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Ceftizoxime.]
[J01DD04, ceftriaxone, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Ceftriaxone.]
[S01AA27, cefuroxime, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefuroxime.]
[N07XX11, pitolisant, Framycetin may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[J01XX09, daptomycin, Framycetin may decrease the excretion rate of Daptomycin which could result in a higher serum level.]
[J01DB01, cephalexin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cephalexin.]
[J01DB02, cephaloridine, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefaloridine.]
[J01DB03, cephalothin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefalotin.]
[J01DB08, cephapirin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefapirin.]
[J01DB09, cephradine, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefradine.]
[A16AX16, givosiran, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Givosiran.]
[M09AX08, golodirsen, Framycetin may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Framycetin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[R02AA03, dichlorobenzyl alcohol, Framycetin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Framycetin may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Rofecoxib.]
[C08CA16, clevidipine, Framycetin may decrease the excretion rate of Clevidipine which could result in a higher serum level.]
[M01AC04, droxicam, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Droxicam.]
[V08CA05, mangafodipir, Framycetin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Dexketoprofen.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Dyclonine.]
[P01BA01, chloroquine, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Chloroquine.]
[N05AA01, chlorpromazine, Framycetin may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.]
[A10BB02, chlorpropamide, Framycetin may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.]
[M03BB03, chlorzoxazone, Framycetin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.]
[N02BA07, ethenzamide, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Ethenzamide.]
[N02BA03, choline salicylate, Framycetin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Etofenamate.]
[M01AX25, chondroitin sulfates, Framycetin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[M01AE05, fenbufen, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Fenbufen.]
[C01CA19, fenoldopam, Framycetin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[J01DD15, cefdinir, Framycetin may decrease the excretion rate of Cefdinir which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Framycetin may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.]
[N02BG07, flupirtine, Framycetin may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[A02BA01, cimetidine, Framycetin may decrease the excretion rate of Cimetidine which could result in a higher serum level.]
[V08CA04, gadoteridol, Framycetin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[S03AA07, ciprofloxacin, Framycetin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.]
[L01XA01, cisplatin, Framycetin may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[V09AB03, ioflupane I-123, Framycetin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Framycetin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Framycetin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[J01FF01, clindamycin, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Clindamycin.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Levobupivacaine.]
[N06AA04, clomipramine, Framycetin may decrease the excretion rate of Clomipramine which could result in a higher serum level.]
[N03AE01, clonazepam, Framycetin may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[J05AH02, oseltamivir, Framycetin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.]
[J01CF02, cloxacillin, The serum concentration of Framycetin can be decreased when it is combined with Cloxacillin.]
[N05AH02, clozapine, Framycetin may decrease the excretion rate of Clozapine which could result in a higher serum level.]
[J01GB12, arbekacin, Framycetin may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Cocaine.]
[M01AX13, proquazone, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Proquazone.]
[J01CA18, hetacillin, The serum concentration of Framycetin can be decreased when it is combined with Hetacillin.]
[M04AC01, colchicine, Framycetin may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Framycetin may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefpirome.]
[A04AA03, tropisetron, Framycetin may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Framycetin may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Imidazole salicylate.]
[B01AC10, indobufen, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Indobufen.]
[J05AB14, valganciclovir, Framycetin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Framycetin may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Framycetin may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Framycetin may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Framycetin may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Framycetin may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Valdecoxib.]
[N02CC05, almotriptan, Framycetin may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Parecoxib.]
[B01AB12, bemiparin, The therapeutic efficacy of Framycetin can be decreased when used in combination with Bemiparin.]
[S01AD03, acyclovir, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Acyclovir.]
[N05BA10, ketazolam, Framycetin may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Kebuzone.]
[N03AX09, lamotrigine, Framycetin may decrease the excretion rate of Lamotrigine which could result in a higher serum level.]
[N07BC04, lofexidine, Framycetin may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[M01AB09, lonazolac, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Lonazolac.]
[M02AA31, loxoprofen, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Loxoprofen.]
[J01DC08, loracarbef, The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Framycetin.]
[C09AA03, lisinopril, Framycetin may decrease the excretion rate of Lisinopril which could result in a higher serum level.]
[A06AD01, magnesium carbonate, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium carbonate.]
[B05XA10, magnesium phosphate, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium phosphate.]
[J01DH02, meropenem, Framycetin may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[J01CA14, methampicillin, The serum concentration of Framycetin can be decreased when it is combined with Metampicillin.]
[N05AD03, metylperon, Framycetin may decrease the excretion rate of Melperone which could result in a higher serum level.]
[J05AF07, tenofovir disoproxil, Framycetin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[S01XA18, cyclosporine, The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Framycetin.]
[M02AA02, mofebutazone, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Morniflumate.]
[M01AH05, etoricoxib, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Etoricoxib.]
[L01AX04, dacarbazine, Framycetin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M03CA01, dantrolene, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Dantrolene.]
[M01AX01, nabumetone, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Nabumetone.]
[N07BB05, nalmefene, Framycetin may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[J01AA01, demeclocycline, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Demeclocycline.]
[S01GX04, nedocromil, Framycetin may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Framycetin may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, Framycetin may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Framycetin may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[M03AC11, cisatracurium, Framycetin may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, Framycetin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.]
[A07EC03, olsalazine, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Olsalazine.]
[N06AA01, desipramine, Framycetin may decrease the excretion rate of Desipramine which could result in a higher serum level.]
[H01BA02, desmopressin, Framycetin may decrease the excretion rate of Desmopressin which could result in a higher serum level.]
[V04CH02, indigo carmine, Framycetin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Framycetin may decrease the excretion rate of Ertapenem which could result in a higher serum level.]
[M01AE12, oxaprozin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Oxaprozin.]
[N06BA02, dextroamphetamine, Framycetin may decrease the excretion rate of Amphetamine which could result in a higher serum level.]
[P03AC04, permethrin, Framycetin may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Framycetin may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[J01CE05, phenethicillin, The serum concentration of Framycetin can be decreased when it is combined with Pheneticillin.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Phenol.]
[R05DA08, pholcodine, Framycetin may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[M05BA02, clodronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Framycetin is combined with Clodronic acid.]
[S01BC03, diclofenac, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Diclofenac.]
[J01CF01, dicloxacillin, The serum concentration of Framycetin can be decreased when it is combined with Dicloxacillin.]
[J05AD01, foscarnet, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Foscarnet.]
[A03AA07, dicyclomine, Framycetin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Framycetin may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C03CA03, piretanide, The serum concentration of Framycetin can be increased when it is combined with Piretanide.]
[C08CA03, isradipine, Framycetin may decrease the excretion rate of Isradipine which could result in a higher serum level.]
[D07XC04, diflucortolone, Framycetin may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Diflunisal.]
[C01AA05, digoxin, Framycetin may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[N02AA03, hydromorphone, Framycetin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.]
[L04AX04, lenalidomide, Framycetin may decrease the excretion rate of Lenalidomide which could result in a higher serum level.]
[J05AE08, atazanavir, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Atazanavir.]
[H03BC01, potassium perchlorate, Framycetin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Framycetin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Pramocaine.]
[V03AB09, dimercaprol, Framycetin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Framycetin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[J01CE03, propicillin, The serum concentration of Framycetin can be decreased when it is combined with Propicillin.]
[N02BB04, propyphenazone, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Proglumetacin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Diphenhydramine.]
[S01AX06, resorcinol, Framycetin may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Framycetin may decrease the excretion rate of Disopyramide which could result in a higher serum level.]
[R06AE09, levocetirizine, Framycetin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Ropivacaine.]
[G04BE08, tadalafil, Framycetin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Ketorolac.]
[C01EB18, ranolazine, Framycetin may decrease the excretion rate of Ranolazine which could result in a higher serum level.]
[N02BA06, salsalate, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Salsalate.]
[H05BA01, salmon calcitonin, Framycetin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.]
[C01CA07, dobutamine, Framycetin may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[C01CA04, dopamine, Framycetin may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA12, doxepin, Framycetin may decrease the excretion rate of Doxepin which could result in a higher serum level.]
[J01AA02, doxycycline, The risk or severity of neuromuscular blockade can be increased when Doxycycline is combined with Framycetin.]
[A08AA10, sibutramine, Framycetin may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[A12CA02, sodium sulfate, Framycetin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Framycetin may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N02CC01, sumatriptan, Framycetin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, Framycetin may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[J01CG02, tazobactam, The therapeutic efficacy of Framycetin can be decreased when used in combination with Tazobactam.]
[J01CA17, temocillin, The serum concentration of Framycetin can be decreased when it is combined with Temocillin.]
[L01AX03, temozolomide, Framycetin may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Tenoxicam.]
[M01AG02, tolfenamic acid, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Tolfenamic acid.]
[N06AG03, toloxatone, Framycetin may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Framycetin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.]
[N03AX11, topiramate, Framycetin may decrease the excretion rate of Topiramate which could result in a higher serum level.]
[C03CA04, torsemide, The serum concentration of Framycetin can be increased when it is combined with Torasemide.]
[J01AA12, tigecycline, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Tigecycline.]
[N05CC01, chloral hydrate, Framycetin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[N06AX16, venlafaxine, Framycetin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[M01AB04, zomepirac, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Zomepirac.]
[N03AX15, zonisamide, Framycetin may decrease the excretion rate of Zonisamide which could result in a higher serum level.]
[L01XA02, carboplatin, The risk or severity of ototoxicity and nephrotoxicity can be increased when Framycetin is combined with Carboplatin.]
[C02AC02, guanfacine, Framycetin may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[L03AX05, pidotimod, Framycetin may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Framycetin may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Framycetin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[G03CA03, estradiol, Framycetin may decrease the excretion rate of Estradiol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Framycetin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[J04AK02, ethambutol, Framycetin may decrease the excretion rate of Ethambutol which could result in a higher serum level.]
[V08CA03, gadodiamide, Framycetin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.]
[C01BD05, ibutilide, Framycetin may decrease the excretion rate of Ibutilide which could result in a higher serum level.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Etidocaine.]
[N01AX07, etomidate, Framycetin may decrease the excretion rate of Etomidate which could result in a higher serum level.]
[L04AD02, tacrolimus, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Tacrolimus.]
[P01AX07, trimetrexate, Framycetin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Framycetin may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, Framycetin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.]
[L02AE02, leuprolide, Framycetin may decrease the excretion rate of Leuprolide which could result in a higher serum level.]
[B05AA05, dextran, Framycetin may decrease the excretion rate of Dextran which could result in a higher serum level.]
[M05BA01, etidronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Framycetin is combined with Etidronic acid.]
[V03AF02, dexrazoxane, Framycetin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.]
[A16AA01, levocarnitine, Framycetin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.]
[M01AE04, fenoprofen, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Fenoprofen.]
[N02AB03, fentanyl, Framycetin may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Framycetin may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[L01BB06, clofarabine, Framycetin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N07AX03, cevimeline, The therapeutic efficacy of Cevimeline can be decreased when used in combination with Framycetin.]
[G04BD02, flavoxate, Framycetin may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Floctafenine.]
[J01CF05, floxacillin, The serum concentration of Framycetin can be decreased when it is combined with Flucloxacillin.]
[J02AC01, fluconazole, Framycetin may decrease the excretion rate of Fluconazole which could result in a higher serum level.]
[J02AX01, flucytosine, Framycetin may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Framycetin may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[L01BC09, floxuridine, Framycetin may decrease the excretion rate of Floxuridine which could result in a higher serum level.]
[N05CD01, flurazepam, Framycetin may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[S01BC04, flurbiprofen, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Flurbiprofen.]
[L02BB01, flutamide, Framycetin may decrease the excretion rate of Flutamide which could result in a higher serum level.]
[V04CX02, folic acid, Framycetin may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[S02AA17, fosfomycin, Framycetin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[M01AG01, mefenamic acid, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Mefenamic acid.]
[C01DA05, pentaerythritol tetranitrate, Framycetin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Framycetin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[L01BC03, tegafur, Framycetin may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[M03AA01, alcuronium, The therapeutic efficacy of Alcuronium can be increased when used in combination with Framycetin.]
[C03CA01, furosemide, Furosemide may increase the ototoxic activities of Framycetin.]
[N05CF04, eszopiclone, Framycetin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.]
[M03AC02, gallamine, The therapeutic efficacy of Gallamine can be increased when used in combination with Framycetin.]
[S01AD09, ganciclovir, Framycetin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AB04, gemfibrozil, Framycetin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Framycetin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A10BB07, glipizide, Framycetin may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Framycetin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.]
[L01EX02, sorafenib, Framycetin may decrease the excretion rate of Sorafenib which could result in a higher serum level.]
[M01CB04, aurothioglucose, Framycetin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Framycetin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Framycetin is combined with Fluindione.]
[C09AA09, fosinopril, Framycetin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[S01EX01, guanethidine, Framycetin may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Framycetin may decrease the excretion rate of Goserelin which could result in a higher serum level.]
[N05AD01, haloperidol, Framycetin may decrease the excretion rate of Haloperidol which could result in a higher serum level.]
[N05AH04, quetiapine, Framycetin may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Framycetin may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[M04AA01, allopurinol, Framycetin may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S01XA14, heparin, The therapeutic efficacy of Framycetin can be decreased when used in combination with Heparin.]
[B05CB03, magnesium citrate, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium citrate.]
[A12CC03, magnesium gluconate, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium gluconate.]
[G03DC01, allylestrenol, Framycetin may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Framycetin.]
[C01CE02, milrinone, Framycetin may decrease the excretion rate of Milrinone which could result in a higher serum level.]
[M02AA26, nimesulide, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Nimesulide.]
[C09AA04, perindopril, Framycetin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C02DB02, hydralazine, Framycetin may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Hydrochlorothiazide.]
[B05XA17, potassium acetate, Framycetin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[V03AB33, hydroxocobalamin, Framycetin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.]
[G04BD06, propiverine, Framycetin may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Framycetin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[M05BA07, risedronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Framycetin is combined with Risedronic acid.]
[R02AX02, ibuprofen, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Ibuprofen.]
[B05XA08, sodium acetate, Framycetin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, Framycetin may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N06AA02, imipramine, Framycetin may decrease the excretion rate of Imipramine which could result in a higher serum level.]
[R01AD07, tixocortol, Framycetin may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, Framycetin may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, Framycetin may decrease the excretion rate of Indapamide which could result in a higher serum level.]
[S01BC01, indomethacin, The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Framycetin.]
[A11HA07, inositol, Framycetin may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Framycetin may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[R01AA02, cyclopentamine, The risk or severity of adverse effects can be increased when Framycetin is combined with Cyclopentamine.]
[S01XA28, varenicline, The therapeutic efficacy of Varenicline can be decreased when used in combination with Framycetin.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Articaine.]
[A10BH01, sitagliptin, Framycetin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Framycetin may decrease the excretion rate of Alprazolam which could result in a higher serum level.]
[N05CH02, ramelteon, Framycetin may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[V03AB01, ipecac, Framycetin may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[J04AC01, isoniazid, Framycetin may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Framycetin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[D10BA01, isotretinoin, Framycetin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[S01AA24, kanamycin, Framycetin may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Framycetin may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[B01AC22, prasugrel, Framycetin may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[M02AA10, ketoprofen, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Ketoprofen.]
[C07AG01, labetalol, Framycetin may decrease the excretion rate of Labetalol which could result in a higher serum level.]
[N04BB01, amantadine, Framycetin may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Framycetin.]
[A06AX03, lubiprostone, Framycetin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[J01CA11, amdinocillin, The serum concentration of Framycetin can be decreased when it is combined with Amdinocillin.]
[J01CA08, amdinocillin pivoxil, The serum concentration of Framycetin can be decreased when it is combined with Pivmecillinam.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Lidocaine.]
[J01FF02, lincomycin, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Lincomycin.]
[S01AA21, amikacin, Framycetin may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N05BA06, lorazepam, Framycetin may decrease the excretion rate of Lorazepam which could result in a higher serum level.]
[J01AA04, lymecycline, The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Framycetin.]
[B05XA11, magnesium chloride, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium chloride.]
[G04BX01, magnesium hydroxide, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium hydroxide.]
[A12CC10, magnesium oxide, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium oxide.]
[V04CC02, magnesium sulfate, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium sulfate.]
[L01BA05, pralatrexate, Framycetin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[V04CX04, mannitol, The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Framycetin.]
[N06AA21, maprotiline, Framycetin may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Framycetin is combined with Mecamylamine.]
[M02AA18, meclofenamic acid, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Meclofenamic acid.]
[B01AB06, nadroparin, The therapeutic efficacy of Framycetin can be decreased when used in combination with Nadroparin.]
[B01AB05, enoxaparin, The therapeutic efficacy of Framycetin can be decreased when used in combination with Enoxaparin.]
[B01AB04, dalteparin, The therapeutic efficacy of Framycetin can be decreased when used in combination with Dalteparin.]
[N06DX01, memantine, Framycetin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Framycetin may decrease the excretion rate of Meperidine which could result in a higher serum level.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Mepivacaine.]
[G04BX16, tiopronin, Framycetin may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Framycetin may decrease the excretion rate of Mersalyl which could result in a higher serum level.]
[N05AX13, paliperidone, Framycetin may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Framycetin may decrease the excretion rate of Metformin which could result in a higher serum level.]
[J01AA05, methacycline, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Metacycline.]
[N07BC02, methadone, Framycetin may decrease the excretion rate of Methadone which could result in a higher serum level.]
[N06BA03, methamphetamine, Framycetin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Framycetin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[H03BB02, methimazole, Framycetin may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BA04, pemetrexed, Framycetin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Framycetin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Methotrexate.]
[D05BA02, methoxsalen, Framycetin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[C02AB01, methyldopa, Framycetin may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[V04CG05, methylene blue, Framycetin may decrease the excretion rate of Methylene blue which could result in a higher serum level.]
[G03EK01, methyltestosterone, Framycetin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, Framycetin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, Framycetin may decrease the excretion rate of Metolazone which could result in a higher serum level.]
[C07AB02, metoprolol, Framycetin may decrease the excretion rate of Metoprolol which could result in a higher serum level.]
[V04CD01, metyrapone, Framycetin may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[J01CA10, mezlocillin, The serum concentration of Framycetin can be decreased when it is combined with Mezlocillin.]
[N02BB03, aminopyrine, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Aminophenazone.]
[B01AB07, parnaparin, The therapeutic efficacy of Framycetin can be decreased when used in combination with Parnaparin.]
[N05CD08, midazolam, Framycetin may decrease the excretion rate of Midazolam which could result in a higher serum level.]
[B01AB10, tinzaparin, The therapeutic efficacy of Framycetin can be decreased when used in combination with Tinzaparin.]
[J05AH01, zanamivir, Framycetin may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[J01AA08, minocycline, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Minocycline.]
[L03AC01, aldesleukin, Framycetin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.]
[N06AA09, amitriptyline, Framycetin may decrease the excretion rate of Amitriptyline which could result in a higher serum level.]
[A04AA05, palonosetron, Framycetin may decrease the excretion rate of Palonosetron which could result in a higher serum level.]
[J01DD06, moxalactam, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Latamoxef.]
[L04AB05, certolizumab pegol, Framycetin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Framycetin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Framycetin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[M03AC03, vecuronium, The therapeutic efficacy of Vecuronium can be increased when used in combination with Framycetin.]
[C07AA12, nadolol, Framycetin may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[J01CA04, amoxicillin, The serum concentration of Framycetin can be decreased when it is combined with Amoxicillin.]
[J01CF06, nafcillin, The serum concentration of Framycetin can be decreased when it is combined with Nafcillin.]
[V03AB15, naloxone, Framycetin may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[N06BA01, amphetamine, Framycetin may decrease the excretion rate of Amphetamine which could result in a higher serum level.]
[M02AA12, naproxen, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Naproxen.]
[N06AX21, duloxetine, Framycetin may decrease the excretion rate of Duloxetine which could result in a higher serum level.]
[N04BX01, tolcapone, Framycetin may decrease the excretion rate of Tolcapone which could result in a higher serum level.]
[S03AA01, neomycin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Neomycin.]
[B01AC17, tirofiban, Framycetin may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[J02AA01, amphotericin B, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Amphotericin B.]
[S01AA19, ampicillin, The serum concentration of Framycetin can be decreased when it is combined with Ampicillin.]
[L03AX16, plerixafor, Framycetin may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Framycetin may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Framycetin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[J05AB11, valacyclovir, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Valaciclovir.]
[C01CE01, inamrinone, Framycetin may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Framycetin is combined with Nicotine.]
[C08CA05, nifedipine, Framycetin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Niflumic acid.]
[C08CA07, nisoldipine, Framycetin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.]
[R07AX01, nitric oxide, Framycetin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Framycetin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, Framycetin may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Framycetin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C02DD01, nitroprusside, Framycetin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[B01AB08, reviparin, The therapeutic efficacy of Framycetin can be decreased when used in combination with Reviparin.]
[N02AA02, opium, Framycetin may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, Framycetin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[M05BA08, zoledronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Framycetin is combined with Zoledronic acid.]
[J01CF04, oxacillin, The serum concentration of Framycetin can be decreased when it is combined with Oxacillin.]
[N05BA04, oxazepam, Framycetin may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[S01GA04, oxymetazoline, The absorption of Framycetin can be decreased when combined with Oxymetazoline.]
[S01BC02, oxyphenbutazone, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Oxyphenbutazone.]
[S01AA04, oxytetracycline, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Oxytetracycline.]
[B01AB09, danaparoid, The therapeutic efficacy of Framycetin can be decreased when used in combination with Danaparoid.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be increased when used in combination with Framycetin.]
[J04AB30, capreomycin, Framycetin may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[A07AA06, paromomycin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Paromomycin.]
[G04BD11, fesoterodine, Framycetin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Framycetin may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[S01AA14, penicillin G, The serum concentration of Framycetin can be decreased when it is combined with Benzylpenicillin.]
[J01CE09, penicillin G procaine, The serum concentration of Framycetin can be decreased when it is combined with Procaine benzylpenicillin.]
[J01CE02, penicillin V, The serum concentration of Framycetin can be decreased when it is combined with Phenoxymethylpenicillin.]
[N05CA01, pentobarbital, Framycetin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.]
[L01XX08, pentostatin, Framycetin may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Framycetin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[G04BX06, phenazopyridine, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Phenazopyridine.]
[N06AF03, phenelzine, Framycetin may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Framycetin is combined with Phenindione.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Framycetin is combined with Phenprocoumon.]
[V03AB36, phentolamine, Framycetin may decrease the excretion rate of Phentolamine which could result in a higher serum level.]
[M02AA01, phenylbutazone, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Phenylbutazone.]
[S01AE05, levofloxacin, Framycetin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Framycetin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Framycetin.]
[S01EB01, pilocarpine, The therapeutic efficacy of Pilocarpine can be decreased when used in combination with Framycetin.]
[C07AA03, pindolol, Framycetin may decrease the excretion rate of Pindolol which could result in a higher serum level.]
[J01CA12, piperacillin, The serum concentration of Framycetin can be decreased when it is combined with Piperacillin.]
[N06BX03, piracetam, Framycetin may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Piroxicam.]
[J01DD16, cefditoren, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefditoren.]
[J01CA02, pivampicillin, The serum concentration of Framycetin can be decreased when it is combined with Pivampicillin.]
[A10BG02, rosiglitazone, Framycetin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.]
[S03AA03, polymyxin B, The risk or severity of adverse effects can be increased when Framycetin is combined with Polymyxin B.]
[A10BH03, saxagliptin, Framycetin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Framycetin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[H02AB07, prednisone, Framycetin may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Prilocaine.]
[M04AB01, probenecid, Framycetin may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, Framycetin may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Procaine.]
[C10AB05, fenofibrate, Framycetin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R06AD02, promethazine, Framycetin may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[A03AB05, propantheline, Framycetin may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[C07AA05, propranolol, Framycetin may decrease the excretion rate of Propranolol which could result in a higher serum level.]
[N02CC04, rizatriptan, Framycetin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Framycetin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[N07XX07, dalfampridine, Framycetin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, The therapeutic efficacy of Pyrantel can be increased when used in combination with Framycetin.]
[J04AK01, pyrazinamide, Framycetin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.]
[C01BA01, quinidine, Framycetin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Quinine.]
[A02BA02, ranitidine, Framycetin may decrease the excretion rate of Ranitidine which could result in a higher serum level.]
[C02AA02, reserpine, Framycetin may decrease the excretion rate of Reserpine which could result in a higher serum level.]
[J05AP01, ribavirin, Framycetin may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[J01AA09, rolitetracycline, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Rolitetracycline.]
[N02BA05, salicylamide, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Salicylic acid.]
[N05CA06, secobarbital, Framycetin may decrease the excretion rate of Secobarbital which could result in a higher serum level.]
[J01GB08, sisomicin, Framycetin may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Framycetin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Framycetin may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[M05BA04, alendronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Framycetin is combined with Alendronic acid.]
[C01DA14, isosorbide mononitrate, Framycetin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D10AX03, azelaic acid, Framycetin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Tiaprofenic acid.]
[C03CC01, ethacrynic acid, The serum concentration of Framycetin can be increased when it is combined with Etacrynic acid.]
